SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS/A - Annual Report to Security Holders: [Amend]
SEC Accession No. 0001837607-24-000061
Filing Date
2024-05-14
Accepted
2024-05-14 09:15:36
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-05-14

Document Format Files

Seq Description Document Type Size
1 ARS/A aeon-20231231xarsa.pdf ARS/A 1730089
  Complete submission text file 0001837607-24-000061.txt   2384471
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS/A | Act: 34 | File No.: 001-40021 | Film No.: 24941718
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)